The Journal of Immunology, Vol 152, Issue 9 4270-4281, Copyright © 1994 by American Association of Immunologists

ARTICLES

The induction of peripheral tolerance by the chronic activation and deletion of CD4+V beta 5+ cells

PJ Fink, CA Fang and GL Turk
Department of Immunology, University of Washington, Seattle 98195.

In C57BL/6 mice transgenic for a rearranged gene encoding a V beta 5+ beta-chain of the TCR, transgene expression among CD4+ cells decreases with age, such that approximately 40% of CD4+ cells express an endogenous beta-chain gene in 8-mo-old mice. A similar deletion of V beta 5+ cells is observed among CD4+ cells from nontransgenic littermates. V beta 5+ T cells are deleted intrathymically in I-E+Mtv- 9+ strains of mice, but this chronic deletion occurs in the lymphoid periphery, in the absence of I-E. We now demonstrate the increased expression of the activation markers CD44 and VLA-4 among CD4+V beta 5+ cells, in the absence of either an increase in size or IL-2 receptor expression. Functional as well as phenotypic differences distinguish CD4+ from CD8+ cells in older V beta 5+ transgenic mice. Relative to their CD8+ counterparts, CD4+V beta 5+ cells are hyporesponsive to plate-bound anti-V beta 5 Abs, and this anergy is partially reversible by the addition of exogenous IL-2. These data suggest the deletion of CD4+V beta 5+ cells is the result of a process that includes their activation, loss of function, and their eventual removal. To investigate the involvement of the principal V beta 5 superantigen Mtv- 9 in this chronic deletion, we have derived several lines of V beta 5+I- E-Mtv-9- mice. Transgene expression also declines with age in CD4+ T cells in these mice, clearly demonstrating that the chronic deletion of CD4+V beta 5+ cells does not require Mtv-9. There is considerable variation in the kinetics and efficiency of CD4+V beta 5+ deletion between lines of Mtv-9- transgenic mice that is not from differences in the profiles of endogenous mammary tumor proviruses nor readily explained by environmental differences that influence proviral expression. These results suggest the existence of genetic factors other than mammary tumor proviruses that influence the deletion of CD4+V beta 5+ cells in the absence of I-E.

This article has been cited by other articles:

				S. C. Jones, K. Clise-Dwyer, G. Huston, J. Dibble, S. Eaton, L. Haynes, and S. L. Swain Impact of Post-Thymic Cellular Longevity on the Development of Age-Associated CD4+ T Cell Defects J. Immunol., April 1, 2008; 180(7): 4465 - 4475. [Abstract] [Full Text] [PDF]

				D. Zehn, M. J. Bevan, and P. J. Fink Cutting Edge: TCR Revision Affects Predominantly Foxp3 Cells and Skews Them toward the Th17 Lineage J. Immunol., November 1, 2007; 179(9): 5653 - 5657. [Abstract] [Full Text] [PDF]

				C. J. Cooper, G. L. Turk, M. Sun, A. G. Farr, and P. J. Fink Cutting Edge: TCR Revision Occurs in Germinal Centers J. Immunol., December 1, 2004; 173(11): 6532 - 6536. [Abstract] [Full Text] [PDF]

				M. Ali, M. Weinreich, S. Balcaitis, C. J. Cooper, and P. J. Fink Differential Regulation of Peripheral CD4+ T Cell Tolerance Induced by Deletion and TCR Revision J. Immunol., December 1, 2003; 171(11): 6290 - 6296. [Abstract] [Full Text] [PDF]

				C. J. Cooper, M. T. Orr, C. J. McMahan, and P. J. Fink T Cell Receptor Revision Does Not Solely Target Recent Thymic Emigrants J. Immunol., July 1, 2003; 171(1): 226 - 233. [Abstract] [Full Text] [PDF]

				C.-Y. Huang, R. Golub, G. E. Wu, and O. Kanagawa Superantigen-Induced TCR {alpha} Locus Secondary Rearrangement: Role in Tolerance Induction J. Immunol., April 1, 2002; 168(7): 3259 - 3265. [Abstract] [Full Text] [PDF]

				C. J. McMahan and P. J. Fink Receptor Revision in Peripheral T Cells Creates a Diverse V{beta} Repertoire J. Immunol., December 15, 2000; 165(12): 6902 - 6907. [Abstract] [Full Text] [PDF]

				A. Barnett, F. Mustafa, T. J. Wrona, M. Lozano, and J. P. Dudley Expression of Mouse Mammary Tumor Virus Superantigen mRNA in the Thymus Correlates with Kinetics of Self-Reactive T-Cell Loss J. Virol., August 1, 1999; 73(8): 6634 - 6645. [Abstract] [Full Text]

				C. A. Blish, S. R. Dillon, A. G. Farr, and P. J. Fink Anergic CD8+ T Cells Can Persist and Function In Vivo J. Immunol., July 1, 1999; 163(1): 155 - 164. [Abstract] [Full Text] [PDF]

				C. A. Blish, B. J. Gallay, G. L. Turk, K. M. Kline, W. Wheat, and P. J. Fink Chronic Modulation of the TCR Repertoire in the Lymphoid Periphery J. Immunol., March 15, 1999; 162(6): 3131 - 3140. [Abstract] [Full Text] [PDF]

				M. Noguchi, A. Sarin, M. J. Aman, H. Nakajima, E. W. Shores, P. A. Henkart, and W. J. Leonard Functional cleavage of the common cytokine receptor gamma  chain (gamma c) by calpain PNAS, October 14, 1997; 94(21): 11534 - 11539. [Abstract] [Full Text] [PDF]